PCM
Pentwater Capital Management’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $178K | Hold |
181,290
| – | – | ﹤0.01% | 64 |
|
|
2025
Q1 | $261K | Hold |
181,290
| – | – | ﹤0.01% | 63 |
|
|
2024
Q4 | $399K | Hold |
181,290
| – | – | ﹤0.01% | 52 |
|
|
2024
Q3 | $299K | Hold |
181,290
| – | – | ﹤0.01% | 47 |
|
|
2024
Q2 | $402K | Buy |
+181,290
| New | +$402K | 0.01% | 51 |
|
|
2023
Q3 | – | Sell |
-181,290
| Closed | -$252K | – | 77 |
|
|
2023
Q2 | $252K | Hold |
181,290
| – | – | ﹤0.01% | 84 |
|
|
2023
Q1 | $288K | Buy |
181,290
+41,163
| +29% | +$65.4K | ﹤0.01% | 87 |
|
|
2022
Q4 | $873K | Sell |
140,127
-114,965
| -45% | -$716K | 0.02% | 65 |
|
|
2022
Q3 | $1.71M | Sell |
255,092
-68,610
| -21% | -$460K | 0.02% | 75 |
|
|
2022
Q2 | $2.06M | Sell |
323,702
-34,304
| -10% | -$218K | 0.02% | 85 |
|
|
2022
Q1 | $1.66M | Sell |
358,006
-4,574
| -1% | -$21.2K | 0.02% | 88 |
|
|
2021
Q4 | $1.81M | Buy |
+362,580
| New | +$1.81M | 0.02% | 100 |
|
|
2021
Q3 | – | Sell |
-289,183
| Closed | -$6.12M | – | 204 |
|
|
2021
Q2 | $6.12M | Sell |
289,183
-318,397
| -52% | -$6.73M | 0.05% | 64 |
|
|
2021
Q1 | $17M | Buy |
607,580
+110,000
| +22% | +$3.09M | 0.16% | 45 |
|
|
2020
Q4 | $12.9M | Sell |
497,580
-1,671,442
| -77% | -$43.5M | 0.16% | 39 |
|
|
2020
Q3 | $80.6M | Sell |
2,169,022
-73,500
| -3% | -$2.73M | 1.04% | 19 |
|
|
2020
Q2 | $115M | Sell |
2,242,522
-70,500
| -3% | -$3.62M | 2.05% | 11 |
|
|
2020
Q1 | $72.9M | Buy |
2,313,022
+59,761
| +3% | +$1.88M | 1.2% | 19 |
|
|
2019
Q4 | $134M | Sell |
2,253,261
-225,000
| -9% | -$13.4M | 2.2% | 8 |
|
|
2019
Q3 | $90.9M | Buy |
2,478,261
+42,761
| +2% | +$1.57M | 1.42% | 9 |
|
|
2019
Q2 | $113M | Sell |
2,435,500
-41,000
| -2% | -$1.91M | 1.22% | 12 |
|
|
2019
Q1 | $99.4M | Sell |
2,476,500
-10,800
| -0.4% | -$434K | 1.25% | 11 |
|
|
2018
Q4 | $114M | Buy |
2,487,300
+135,800
| +6% | +$6.25M | 0.98% | 10 |
|
|
2018
Q3 | $104M | Sell |
2,351,500
-112,500
| -5% | -$4.99M | 0.88% | 11 |
|
|
2018
Q2 | $96.6M | Buy |
2,464,000
+153,500
| +7% | +$6.02M | 0.71% | 14 |
|
|
2018
Q1 | $167M | Buy |
2,310,500
+381,269
| +20% | +$27.6M | 1.18% | 15 |
|
|
2017
Q4 | $127M | Sell |
1,929,231
-313,969
| -14% | -$20.7M | 0.84% | 12 |
|
|
2017
Q3 | $112M | Buy |
2,243,200
+255,200
| +13% | +$12.8M | 0.96% | 12 |
|
|
2017
Q2 | $92M | Buy |
1,988,000
+151,800
| +8% | +$7.03M | 0.84% | 16 |
|
|
2017
Q1 | $64.8M | Buy |
1,836,200
+8,200
| +0.4% | +$290K | 0.79% | 15 |
|
|
2016
Q4 | $22.9M | Buy |
1,828,000
+292,000
| +19% | +$3.66M | 0.29% | 20 |
|
|
2016
Q3 | $21.3M | Buy |
1,536,000
+18,000
| +1% | +$249K | 0.2% | 30 |
|
|
2016
Q2 | $15M | Buy |
1,518,000
+94,000
| +7% | +$929K | 0.2% | 25 |
|
|
2016
Q1 | $24.1M | Sell |
1,424,000
-15,000
| -1% | -$254K | 0.18% | 21 |
|
|
2015
Q4 | $32M | Sell |
1,439,000
-11,000
| -0.8% | -$245K | 0.22% | 25 |
|
|
2015
Q3 | $34.2M | Sell |
1,450,000
-68,000
| -4% | -$1.6M | 0.3% | 28 |
|
|
2015
Q2 | $124M | Buy |
1,518,000
+222,000
| +17% | +$18.2M | 0.66% | 22 |
|
|
2015
Q1 | $120M | Sell |
1,296,000
-174,000
| -12% | -$16.1M | 0.9% | 17 |
|
|
2014
Q4 | $59.4M | Buy |
1,470,000
+480,000
| +48% | +$19.4M | 0.42% | 21 |
|
|
2014
Q3 | $24.2M | Sell |
990,000
-10,000
| -1% | -$245K | 0.23% | 37 |
|
|
2014
Q2 | $15.8M | Buy |
1,000,000
+113,776
| +13% | +$1.8M | 0.17% | 33 |
|
|
2014
Q1 | $13.4M | Buy |
886,224
+244,324
| +38% | +$3.69M | 0.36% | 28 |
|
|
2013
Q4 | $8.82M | Buy |
641,900
+210,846
| +49% | +$2.9M | 0.25% | 37 |
|
|
2013
Q3 | $8.13M | Buy |
+431,054
| New | +$8.13M | 0.23% | 42 |
|